Advertisement

Advertisement

AACR Virtual Meeting: COVID-19 and Cancer 2021

covid-19

Toni K. Choueiri, MD, on the Effects of Cancer Treatments on Patients Infected With COVID-19

Toni K. Choueiri, MD, of Dana-Farber Cancer Institute, discusses the challenges of delivering optimal cancer treatments in the face of the coronavirus pandemic. Focusing on systemic therapies, he revi...

Lymphoma
COVID-19
Immunotherapy

Patients With Lymphoma Receiving B-Cell–Depleting Therapies May Be at Greater Risk for Persistent COVID-19 Infection

B-cell–depleting immunotherapy may cause B-cell aplasia and impair the body’s immune response. A retrospective, multicentric French study of patients with lymphoma and persistent COVID-19 infection ha...

COVID-19

Patients on Active Chemotherapy May Not Be at Increased Risk for COVID-19 Infection

Due to concerns that patients with cancer may be at higher risk for contracting the coronavirus—and may have more severe complications if infected—during the COVID-19 pandemic, hospitals and clinical ...

Colorectal Cancer
COVID-19
Issues in Oncology

Socially Distant Drive-by FluFIT Clinics May Increase Colorectal Cancer Screening Rates Among Black Patients During the COVID-19 Pandemic

Administering colorectal cancer screening kits through a socially distant drive-by flu vaccination clinic increased access to colorectal cancer screening among Black Americans, according to results pr...

Advertisement

Advertisement



Advertisement